Form D · Biotechnology

Trinity Nuclein Rd II QP Investors LLC

Southlake, TX · CIK 0001935791

Offering snapshot reported Jul 29, 2022 · SEC filing

Reported sold
$6.98M
Offering amount: $15M
Investors reported
62
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 14, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.49M$6.98MJul 26, 2022: $6,625,000.00Jul 26, 2022Jul 29, 2022: $6,975,000.00Jul 29, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,625,000 → $6,975,000
  • Reported investors61 → 62

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 29, 2022Amendment$6,975,000$350,000vs Jul 26, 202262SEC filing
Jul 26, 2022Initial$6,625,000No comparison61SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$448K (estimated)
Finders' fees
$0
Form D file number
021-453767
$6,975,000 x 7% = $448,250

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
TPEG Securities LLC146726

Source: Form D, filed Jul 29, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

TRINITY NUCLEIN RD II QP INVESTORS LLC

Investment adviser: TRINITY INVESTORS FUND ADVISORS, LLC

Gross asset value
$9.68M
Beneficial owners
93
ADV minimum commitment
$50K

Reported in Form ADV on May 20, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Custodian EQUITY TRUST COMPANY FORT MYERS, Florida, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No
Filing source

Form ADV 2107310 · May 20, 2026 · Schedule D 7.B.(1), fund 805-9525538594

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sanjay Chandra Executive
Dan Meader Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
925 S Kimball Ave Ste 100
Southlake, TX, 76092